Profil
Colleen DeSimone worked as the Chief Accounting Officer, VP-Finance & Controller at Syros Pharmaceuticals, Inc. from 2017 to 2018.
Prior to that, she worked as the Secretary & Treasurer at Cedilla Therapeutics, Inc. Ms. DeSimone completed her undergraduate degree at Holy Cross College (Indiana).
Ehemalige bekannte Positionen von Colleen DeSimone
| Unternehmen | Position | Ende |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 09.03.2018 |
Cedilla Therapeutics, Inc.
 Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Unternehmenssekretär | - |
Ausbildung von Colleen DeSimone
| Holy Cross College (Indiana) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SYROS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Health Technology |
